Kohl's Corporation Peer Comparison
Metric | Value | Ranking | |||||
---|---|---|---|---|---|---|---|
Market Cap | $1.3 Billion | 4/5 | DDS $7.9B |
M $4.1B |
JWN $4.0B |
KSS $1.3B |
CBD $220.5M |
Gross Margin | 1% | 4/5 | DDS 100% |
M 42% |
CBD 22% |
KSS 1% |
JWN -75% |
Profit Margin | 1% | 3/5 | DDS 9% |
JWN 4% |
KSS 1% |
M 1% |
CBD -7% |
EBITDA margin | 8% | 2/5 | DDS 14% |
KSS 8% |
CBD 6% |
M 1% |
JWN -14% |
Quarterly Revenue | $3.7 Billion | 2/5 | M $4.9B |
KSS $3.7B |
JWN $3.5B |
DDS $1.4B |
CBD $922.8M |
Quarterly Earnings | $22.0 Million | 4/5 | JWN $135.0M |
DDS $124.6M |
M $28.0M |
KSS $22.0M |
CBD -$63.9M |
Quarterly Free Cash Flow | $44.0 Million | 1/5 | KSS $44.0M |
CBD $21.1M |
JWN -$274.0M |
M -$384.0M |
DDS -$0 |
Trailing 4 Quarters Revenue | $17.2 Billion | 2/5 | M $23.9B |
KSS $17.2B |
JWN $14.7B |
DDS $6.8B |
CBD $2.8B |
Trailing 4 Quarters Earnings | -$263.0 Million | 4/5 | M $4.9B |
KSS $3.7B |
JWN $3.5B |
DDS $1.4B |
CBD $922.8M |
Quarterly Earnings Growth | -77% | 5/5 | JWN 775% |
CBD 76% |
DDS -34% |
M -74% |
KSS -77% |
Annual Earnings Growth | -150% | 5/5 | CBD 49% |
DDS 10% |
M -28% |
JWN -48% |
KSS -150% |
Quarterly Revenue Growth | -13% | 5/5 | JWN -2% |
CBD -5% |
DDS -8% |
M -10% |
KSS -13% |
Annual Revenue Growth | 4% | 3/5 | DDS 8% |
M 7% |
KSS 4% |
JWN -7% |
CBD -29% |
Cash On Hand | $174.0 Million | 5/5 | DDS $980.4M |
CBD $470.0M |
JWN $397.0M |
M $315.0M |
KSS $174.0M |
Short Term Debt | $80.0 Million | 4/5 | CBD $436.3M |
JWN $246.0M |
M $92.0M |
KSS $80.0M |
DDS $11.7M |
Long Term Debt | $2.9 Billion | 2/5 | M $5.7B |
KSS $2.9B |
JWN $1.4B |
CBD $1.3B |
DDS $345.9M |
PE | -1.00 | 4/5 | JWN 21.56 |
DDS 10.54 |
M 6.13 |
KSS -1.00 |
CBD -1.00 |
PS | 0.08 | 5/5 | DDS 1.16 |
CBD 0.39 |
JWN 0.27 |
M 0.17 |
KSS 0.08 |
PB | 0.17 | 5/5 | JWN 4.06 |
DDS 3.09 |
M 0.99 |
CBD 0.27 |
KSS 0.17 |
PC | 7.43 | 4/5 | M 13.03 |
JWN 10.10 |
DDS 8.03 |
KSS 7.43 |
CBD 0.47 |
Liabilities to Equity | 0.49 | 5/5 | JWN 8.44 |
CBD 4.36 |
M 0.76 |
DDS 0.62 |
KSS 0.49 |
ROA | -0.02 | 5/5 | DDS 18% | M 4% | JWN 2% | CBD -1% | KSS -2% |
ROE | -0.02 | 4/5 | DDS 29% |
JWN 19% |
M 4% |
KSS -2% |
CBD -7% |
Current Ratio | 2.05 | 2/5 | DDS 2.61 |
KSS 2.05 |
M 1.32 |
CBD 1.23 |
JWN 1.12 |
Quick Ratio | 0.02 | 4/5 | JWN 21.56 |
DDS 10.54 |
M 6.13 |
KSS -1.00 |
CBD -1.00 |
Long Term Debt to Equity | 0.19 | 4/5 | CBD} 1.60 |
JWN} 1.47 |
M} 0.33 |
KSS} 0.19 |
DDS} 0.14 |
Debt to Equity | 0.20 | 4/5 | JWN 1.72 |
CBD 1.19 |
M 0.34 |
KSS 0.20 |
DDS 0.14 |
Burn Rate | 1.53 | 2/5 | CBD 2.69 |
KSS 1.53 |
M 1.40 |
DDS -9.09 |
JWN -25.48 |
Cash to Cap | 0.13 | 2/5 | CBD 2.13 |
KSS 0.13 |
DDS 0.12 |
JWN 0.10 |
M 0.08 |
CCR | 2.00 | 1/5 | KSS 2.00 |
CBD -0.33 |
JWN -2.03 |
M -13.71 |
DDS |
EV to EBITDA | 14.49 | 3/5 | M} 150.23 |
DDS} 35.85 |
KSS} 14.49 |
CBD} 9.19 |
JWN} -11.08 |
EV to Revenue | 0.24 | 5/5 | DDS 1.07 |
CBD 0.91 |
M 0.40 |
JWN 0.36 |
KSS 0.24 |